- Filed
- Jul 13, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · Jul 7, 2020 | 3.11B sh |
| Shares Diluted | Q1 2020 · Mar 31, 2020 | 9.88B sh |
| Shares Diluted | Q1 2020 · Mar 31, 2019 | 38.05M sh |
| Operating Cash Flow | Q1 2020 · Mar 31, 2020 | −$240.72K |
| Operating Cash Flow | Q1 2020 · Mar 31, 2018 | −$274.12K |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $0 |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $0 |
| Cash And Equivalents restated | Q1 2020 · Mar 31, 2018 | $130.97K |
| Cash And Equivalents restated | Q1 2020 · Dec 31, 2017 | $9.64K |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | −$4.44M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | −$5.7M |
| Stockholders Equity | Q1 2020 · Mar 31, 2019 | −$3.38M |
| Stockholders Equity | Q1 2020 · Dec 31, 2018 | −$2.37M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $5.47M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $6.75M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $6.63M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $8M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $150.86K |
| Current Assets | Q1 2020 · Dec 31, 2019 | $140.44K |
| Total Assets | Q1 2020 · Mar 31, 2020 | $2.2M |
| Total Assets | Q1 2020 · Dec 31, 2019 | $2.3M |
| Eps Diluted | Q1 2020 · Mar 31, 2020 | $0.00 |
| Eps Diluted | Q1 2020 · Mar 31, 2019 | −$0.03 |
| Eps Basic | Q1 2020 · Mar 31, 2020 | $0.00 |
| Eps Basic | Q1 2020 · Mar 31, 2019 | −$0.03 |
| Sga Expense | Q1 2020 · Mar 31, 2020 | $240.07K |
| Sga Expense | Q1 2020 · Mar 31, 2019 | $346.83K |
| Net Income | Q1 2020 · Mar 31, 2020 | $1.1M |
| Net Income | Q1 2020 · Mar 31, 2019 | −$1.12M |
| Operating Income | Q1 2020 · Mar 31, 2020 | −$312.8K |
| Operating Income | Q1 2020 · Mar 31, 2019 | −$344.21K |
| Revenue | Q1 2020 · Mar 31, 2020 | $789.44K |
| Revenue | Q1 2020 · Mar 31, 2019 | $839.62K |